Scientists Race to Build a New Vaccine — And the First Tests Have Begun!
Quick Summary
Scientists from the company Moderna have begun testing a brand-new Ebola vaccine on volunteers in Canada. It uses the same clever technology that helped fight COVID-19. The goal is to help protect people during a serious disease outbreak happening right now in central Africa.
What Happened?
The Democratic Republic of Congo (DRC) is a large country in central Africa. Right now, it is dealing with a serious Ebola outbreak. Ebola is a very dangerous illness caused by a virus.
This particular strain of Ebola is called the Bundibugyo strain. It is rare, and until recently, there were no approved vaccines or medicines to treat it. That made fighting this outbreak extra hard for doctors and health workers.
But scientists around the world have been working at incredible speed to change that.
This week, the medicine company Moderna vaccinated the very first volunteers in a Phase 1 clinical trial. That means healthy adult volunteers received a dose of the new experimental vaccine. There were about 80 volunteers participating at testing sites across Canada.
Doctors will watch these volunteers carefully over the coming months. They want to make sure the vaccine is safe and that it helps the body build a defense against the virus.
This vaccine uses a technology called mRNA — the same kind used in the COVID-19 vaccines. Think of mRNA like a tiny instruction card. It teaches your body how to recognize a germ, so if the real germ ever shows up, your immune system already knows what to do.
Before Moderna started, the University of Oxford in the United Kingdom had already begun a similar vaccine trial in July. So now two different teams of scientists are racing to find a solution.
Health workers and volunteers in Congo, Canada, and many other countries are all part of this enormous team effort.
Why Does It Matter?
Scientists and health officials are moving faster than ever before. Normally, getting a vaccine to this stage takes years. This time, it happened in just a few months.
Even if this vaccine takes more time to be fully approved, every test brings scientists closer to a solution — not just for this outbreak, but for any future Ebola outbreak too.
The World Health Organization and Africa CDC have declared the outbreak a public health emergency. That means experts everywhere are paying close attention and working together. Thousands of health workers, researchers, and volunteers are all helping — and that team effort is what gives scientists the best chance of success.
Big Words
- Vaccine — a medicine that teaches your immune system to fight a specific germ, so your body is prepared if it ever meets that germ for real
- Clinical trial — a careful scientific test of a new medicine or vaccine on volunteers to see if it is safe and works well
- mRNA — short for messenger RNA; a tiny set of instructions that tells your cells how to make a protein, which your immune system can then learn to recognize
- Outbreak — when a disease spreads to many people in a region more quickly than expected
- Immune system — your body’s built-in defense system that fights germs, viruses, and bacteria
Fun Fact
The mRNA vaccine technology used here was decades in the making. Scientists had been studying mRNA since the 1990s. When COVID-19 appeared in 2020, all that research meant vaccines could be developed in record time — and now the same technology is helping with Ebola!
Think About It
If you were a scientist working on a new vaccine, what would be the most important thing to check before giving it to people?
Sources
- ABC News — Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak
- CBC News — Health Canada authorizes mRNA vaccine trial for Ebola virus causing huge outbreak in Congo
- Health Canada — Health Canada authorizes vaccine clinical trial for Ebola disease caused by the Bundibugyo virus
- Euronews — Moderna starts human trials for Bundibugyo Ebola vaccine as Congo’s outbreak continues
- UN News — New Ebola vaccine trial launches as outbreak spreads in DR Congo